General Information
|
|
Product
|
Parkin Antibody Western Blot Positive Control
|
Verified Applications
|
WB
|
Immunogen
|
Purified Protein
|
Accession #
|
GenBank: BAA25751.1
|
Physical Properties
|
|
Quantity
|
5 Applications
|
Volume
|
Inquire
|
Form
|
Western Blot Positive Control
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Western Blot
|
1:500
|
Protein
|
Uniprot #
|
O60260
|
Overview
|
Acts within a multiprotein E3 ubiquitin ligase complex, by catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. It also participates in the removal and/or detoxification of proteins that are abnormally folded or damaged.
|
Molecular Function
|
Ligase, Chaperone binding, Protein kinase binding
|
Subcellular Location
|
Cytoplasm, Nucleus, Endoplasmic reticulum, Mitochondrion
|
Expression
|
Expressed highly in the brain, and is also expressed in the heart, testis and skeletal muscle. Expression is down-regulated or absent in tumor biopsies and in the brain of PARK2 patients.
|
Structure
|
Forms E3 ubiquitin ligase complex with UBE2L3 or UBE2L6. Binds to C2A and C2B domains of SYTqq and interacts and regulates the turnovers of SEPT5.
|
Alternative Nomenclature
|
AR JP antibody
E3 ubiquitin ligase antibody
FRA6E antibody
LPRS 2 antibody
PARK 2 antibody
Parkin 2 antibody
Parkinson disease (autosomal recessive juvenile) 2 antibody
Parkinson protein 2, E3 ubiquitin protein ligase (parkin) antibody
PDJ antibody
PRKN 2 antibody
Ubiquitin E3 ligase PRKN antibody
|
|
|